摘要:
The present invention provides a novel benzene derivative useful as a preventive and medically treating medicine for arteriosclerosis, and a cholesterol O-acyl transferase inhibitor comprising the benzene derivative as an active ingredient.The benzene derivative according to the present invention is represented by the following general formula (I): ##STR1## wherein R.sup.1 represents a carboxyl group which may be protected or a group represented by the formula: ##STR2## wherein R.sup.5 represents a lower alkyl group or a hydroxyalkyl group and R.sup.6 represents a hydrogen atom or a hydroxyl group; R.sup.2 represents a hydrogen atom, a lower alkyl group or the like; R.sup.3 and R.sup.4 each represent a hydrogen atom or a hydroxyl group; and p is an integer of 1 to 6.
摘要:
A benzene, pyridine or pyrimidine derivative having the below shown formula is novel and useful as an anti-arteriosclerotic agent. ##STR1## wherein R.sup.1 stands for a lower alkyl group, an amino group which may be substituted, or the like; R.sup.2 stands for a group represented by the formula: ##STR2## (wherein R.sup.16 stands for an alkyl group having 1 to 6 carbon atoms, or the like) or the like; R.sup.3 stands for a group represented by the formula: --O--(CH.sub.2).sub.m --Y (Y stands for an imidazolyl or piperazinyl group, or the like and m is 1 to 6) or the like; R.sup.5 stands for a hydrogen atom, a lower alkyl group, or the like; A stands for a group represented by the formula: ##STR3## (wherein R.sup.6 stands for a hydrogen atom, a lower alkyl group, or the like), --N.dbd., or the like; and B stands for a group represented by the formula: ##STR4## (wherein R.sup.4 stands for a hydrogen or the like), --N.dbd., or the like.
摘要:
The present invention provides a phosphorus-containing isoprenoid derivative represented by the following general formula (I) or a pharmacologically acceptable salt thereof, which is useful as a preventive and therapeutic agent for diseases for which a squalene synthetase inhibiting action is efficacious: ##STR1## wherein R.sup.1 and R.sup.2 each represent a hydrogen atom, a lower alkyl, cycloalkyl, alkenyl or alkynyl group, an aryl group which may be substituted, an arylalkyl group in which the aryl group may be substituted, or a heteroaryl or heteroarylalkyl group: R.sup.3 and R.sup.4 each represent a hydrogen atom, a lower alkyl group or an alkali metal; Y represents a group represented by the formula: ##STR2## (wherein R.sup.5 and R.sup.6 each represent a hydrogen atom, a lower alkyl group or an alkali metal or a group represented by the formula: --CO.sub.2 R.sup.7 (wherein R.sup.7 represents a hydrogen atom, a lower alkyl group or an alkali metal); Z represents a group represented by the Formula: --(CH.sub.2).sub.m -- (wherein m is an integer of 0 to 3), a group represented by the formula: --(CH.sub.2).sub.p --CH.dbd.CH--(CH.sub.2).sub.q -- (wherein p is 0 or 1 and q is 1 or 2) or a group represented by the Formula: ##STR3## (wherein R.sup.8 represents a hydrogen atom or a lower alkyl group; A represents an alkylene chain which has 1 to 5 carbon atoms and which may have a substituent on each carbon atom; and r is zero or an integer of 1 to 5); and n is zero or an integer of 1 to 5.
摘要:
A phosphonic acid derivative which is useful for medically treating hyperlipemia, represented by the following general formula (I) or a pharmacologically acceptable salt thereof: ##STR1## Representative example of the compound according to the present invention is one represented by the following formula: ##STR2##
摘要:
The present invention provides a preventive or therapeutic agent for diabetes mellitus and diabetic complications, which is a new type based on an adenosine A2 receptor antagonist action.That is, it provides a novel condensed imidazole compound which has an adenosine A2 receptor antagonist action, is effective for preventing or treating diabetes mellitus and diabetic complications, and is represented by the formula (I); (wherein R1 represents e.g. an amino group which may be substituted with an alkyl group; R2 represents e.g. hydrogen atom, an alkyl group, a cycloalkyl group or an alkyl group, alkenyl group or alkynyl group which may be substituted with hydrox etc.; R3 represents e.g. an optionally substituted alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, pyridinone group, pyrimidinone group or piperadinone group; Ar represents e.g. an optionally substituted aryl or heteroaryl group; and Q and W are the same as or different from each other and each represents N or CH), a pharmacologically acceptable salt or hydrates thereof.
摘要翻译:本发明提供了一种基于腺苷A2受体拮抗剂作用的新型糖尿病和糖尿病并发症的预防或治疗剂。即提供了具有腺苷A2受体拮抗剂作用的新颖的缩合咪唑化合物,是 有效预防或治疗糖尿病和糖尿病并发症,并由式(I)表示;(其中R 1表示例如可被烷基取代的氨基; R 2表示例如氢原子, 可以被羟基取代的烷基,环烷基或烷基,烯基或炔基; R 3表示例如任选取代的烷基,烯基,炔基,芳基,杂芳基, 吡啶酮基,嘧啶酮基或哌嗪酮基; Ar表示例如任选取代的芳基或杂芳基; Q和W彼此相同或不同,每个代表 N或CH),其药理学上可接受的盐或其水合物。
摘要:
The present invention provides a high tensile strength steel plate having a chemical composition containing, in percent by mass, 0.03% to 0.12% of C, 0.01% to 0.30% of Si, 0.5% to 1.95% of Mn, 0.008% or less of P, 0.005% or less of S, 0.015% to 0.06% of Al, 0.011% to 0.05% of Nb, 0.005% to 0.02% of Ti, 0.001% to 0.006% of N, 0.0005% to 0.003% of Ca, optionally, one or two or more of Cr, Mo, V, Cu, and Ni, in which Ceq is 0.44 or less, Ti/N is 1.5 to 3.5, and parameter formulas composed of specific elements for controlling the sulfide morphology and the degree of center segregation in the steel are satisfied, and the balance being Fe and incidental impurities, in which the hardness of the center segregation area of the steel sheet is further specified.
摘要:
A liquid developer used for wet-type image forming apparatuses includes toner particles and an insulating liquid, the toner particles include a resin, a pigment, and a pigment dispersant, the pigment includes a pigment having an acid group, and the pigment dispersant is a basic polymer dispersant including units derived from ε-caprolactone.
摘要:
To provide printed seamless cans in small lots having many kinds of designs, the printed seamless cans excellently reproducing the density of the area solidly printed all over the surface and forming vivid images.[Means for Solution] A printed seamless can forming at least a printed layer and a finishing varnish layer on at least the body portion on the outer surface of the seamless can, the printed layer having an image formed by the plate-type printing and an image formed by the ink-jet printing, and being covered with the finishing varnish layer.
摘要:
In order to resolve a problem such that a prior wall-surface travelling robot has dropped from a wall-surface at travelling by that the parallelism between a frame and the wall-surface is not held by rotation moment by its own weight, a wall-surface travelling robot according to the present invention comprises extendable absorption pad mechanisms (3) in each of which absorption pads (3-3) detachable to the wall-surface to be absorbed move parallel to the wall-surface and vertically in the wall-surface, and extend to the wall-surface; and a rotation moment offsetting mechanism (4) for applying a force opposite to the wall-surface into a lower end part (2-1-2) of a frame (2).
摘要:
An ECU for controlling an engine counts the continued period of stopping the engine in a low-temperature environment. The ECU sets the idle rotational speed at a first idle rotational speed when the stopped period is below a predetermined threshold value, and at a second idle rotational speed higher than the first idle rotational speed when the stopped period exceeds the reference value. Accordingly, resonance at the driving force transmission system during idle operation can be prevented even in the case where a mount employed for attaching the engine to the vehicle is hardened as a result of undergoing a low-temperature environment for a long period of time, and the resonant rotational speed of the driving force transmission system including the engine varies.